Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sugen continues to focus on TK inhibitors

Feb. 19, 1997

Aphton and Pasteur Merieux Connaught form immunotherapy product alliance

Feb. 18, 1997

AEterna clarifies Neovastat clinical development program

Feb. 18, 1997

Mechanism of antitumor effect of natural lipopolysaccharide

Feb. 18, 1997

Progen's lead compound shows promise for cancer/metastasis

Feb. 18, 1997

Apoptosis-regulating factor discovered

Feb. 17, 1997

Chiron prepares uPA inhibitors

Feb. 17, 1997

Human Genome Sciences discloses novel human polypeptide for cancer

Feb. 17, 1997

BASF focuses on dolastatin derivatives

Feb. 17, 1997

TK signal transduction modulators claimed by Sugen

Feb. 17, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...